We are live on ! Find out more
LAB icon

Standard BioTools
LAB

141 hedge funds and large institutions have $543M invested in Standard BioTools in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

13% more capital invested

Capital invested by funds: $480M → $543M (+$62.5M)

2.53% more ownership

Funds ownership: 73.23% → 75.76% (+2.5%)

5% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 22

2% less funds holding

Funds holding: 144 → 141 (-3)

11% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 45

21% less call options, than puts

Call options by funds: $72K | Put options by funds: $91K

Holders
141
Holders Change
-3
Holders Change %
-2.08%
% of All Funds
2.02%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
21
Increased
40
Reduced
45
Closed
22
Calls
$72K
Puts
$91K
Net Calls
-$19K
Net Calls Change
-$1.17M

Top Buyers

1
CC
Casdin Capital
New York
+$14.3M
2
HBWM
Hollow Brook Wealth Management
New York
+$10.8M
3
Morgan Stanley
Morgan Stanley
New York
+$4.53M
4
Northern Trust
Northern Trust
Illinois
+$3.19M
5
Charles Schwab
Charles Schwab
California
+$3.13M

Top Sellers

1
AIM
ARK Investment Management
Florida
-$7.3M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$2.14M
3
NAMA
Nikko Asset Management Americas
New York
-$2.09M
4
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$2.08M
5
ICM
Invenomic Capital Management
Massachusetts
-$1.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
51
T. Rowe Price Associates
Maryland
$319K -$98 -50 -0%
Commonwealth Equity Services
52
Commonwealth Equity Services
Massachusetts
$318K +$17.2K +8,802 +6%
Invesco
53
Invesco
Georgia
$314K +$1.83K +936 +0.6%
Rockefeller Capital Management
54
Rockefeller Capital Management
New York
$312K +$1.96K +1,000 +0.6%
Mirae Asset Global ETFs Holdings
55
Mirae Asset Global ETFs Holdings
Hong Kong
$312K +$316K +161,473 New
CF
56
Corebridge Financial
Texas
$304K -$8.98K -4,588 -3%
MIM
57
MetLife Investment Management
New Jersey
$277K +$130K +66,410 +86%
Wells Fargo
58
Wells Fargo
California
$271K +$13.4K +6,831 +5%
JP Morgan Chase
59
JP Morgan Chase
New York
$270K +$19.6K +9,995 +8%
Qube Research & Technologies (QRT)
60
Qube Research & Technologies (QRT)
United Kingdom
$267K -$2.14M -1,090,992 -89%
Janus Henderson Group
61
Janus Henderson Group
United Kingdom
$253K – – –
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$220K -$6.18K -3,156 -3%
EC
63
EntryPoint Capital
New York
$220K +$223K +113,867 New
SG Americas Securities
64
SG Americas Securities
New York
$195K +$104K +52,970 +110%
ECM
65
ExodusPoint Capital Management
New York
$194K +$196K +100,309 New
VOYA Investment Management
66
VOYA Investment Management
Georgia
$189K -$9.72K -4,966 -5%
BNP Paribas Financial Markets
67
BNP Paribas Financial Markets
France
$183K -$80.7K -41,231 -30%
AQR Capital Management
68
AQR Capital Management
Connecticut
$168K -$306K -156,063 -64%
XT
69
XTX Topco
Cayman Islands
$162K +$93.7K +47,852 +133%
WC
70
Wexford Capital
Florida
$161K -$47K -23,981 -22%
HighTower Advisors
71
HighTower Advisors
Illinois
$160K -$11.8K -6,000 -7%
HSBC Holdings
72
HSBC Holdings
United Kingdom
$157K +$65.8K +33,609 +69%
Susquehanna International Group
73
Susquehanna International Group
Pennsylvania
$154K -$281K -143,296 -64%
New York State Common Retirement Fund
74
New York State Common Retirement Fund
New York
$152K -$84.6K -43,200 -35%
SC
75
Schoolcraft Capital
Colorado
$143K – – –
1 2
3
4 5

LAB Hedge Fund Activity: Q3 2024 in Review

141 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2024, worth a combined $543M — up 13% from $480M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of LAB and 21 opened new positions — a net loss of 1 holder — while 45 trimmed existing stakes and 40 added.

The largest buyer was Casdin Capital, adding an estimated $14.3M. The largest seller was ARK Investment Management, cutting an estimated $7.3M.

  • 141 institutional investors held Standard BioTools (LAB) as of Q3 2024, down from 144 in Q2 2024.
  • Funds reported $543M of Standard BioTools stock for Q3 2024, up 13% quarter-over-quarter.
  • 21 funds opened new Standard BioTools positions in Q3 2024 and 22 closed out, a net change of -1 holder.
  • The largest Standard BioTools buyer in Q3 2024 was Casdin Capital, an estimated $14.3M added.
  • The largest Standard BioTools seller in Q3 2024 was ARK Investment Management, an estimated $7.3M sold.

Based on aggregated 13F filings for Q3 2024.